1. Home
  2. DRMA vs LICN Comparison

DRMA vs LICN Comparison

Compare DRMA & LICN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DRMA
  • LICN
  • Stock Information
  • Founded
  • DRMA 2014
  • LICN 2004
  • Country
  • DRMA United States
  • LICN China
  • Employees
  • DRMA N/A
  • LICN N/A
  • Industry
  • DRMA Biotechnology: Pharmaceutical Preparations
  • LICN
  • Sector
  • DRMA Health Care
  • LICN
  • Exchange
  • DRMA Nasdaq
  • LICN Nasdaq
  • Market Cap
  • DRMA 4.5M
  • LICN 4.2M
  • IPO Year
  • DRMA 2021
  • LICN 2023
  • Fundamental
  • Price
  • DRMA $0.75
  • LICN $4.24
  • Analyst Decision
  • DRMA Strong Buy
  • LICN
  • Analyst Count
  • DRMA 1
  • LICN 0
  • Target Price
  • DRMA $3.00
  • LICN N/A
  • AVG Volume (30 Days)
  • DRMA 71.6K
  • LICN 1.7M
  • Earning Date
  • DRMA 05-14-2025
  • LICN 01-01-0001
  • Dividend Yield
  • DRMA N/A
  • LICN N/A
  • EPS Growth
  • DRMA N/A
  • LICN N/A
  • EPS
  • DRMA N/A
  • LICN N/A
  • Revenue
  • DRMA N/A
  • LICN $41,477,000.00
  • Revenue This Year
  • DRMA N/A
  • LICN N/A
  • Revenue Next Year
  • DRMA N/A
  • LICN N/A
  • P/E Ratio
  • DRMA N/A
  • LICN N/A
  • Revenue Growth
  • DRMA N/A
  • LICN 4.32
  • 52 Week Low
  • DRMA $0.66
  • LICN $2.60
  • 52 Week High
  • DRMA $5.00
  • LICN $488.00
  • Technical
  • Relative Strength Index (RSI)
  • DRMA 44.67
  • LICN 42.54
  • Support Level
  • DRMA $0.66
  • LICN $4.86
  • Resistance Level
  • DRMA $0.75
  • LICN $6.16
  • Average True Range (ATR)
  • DRMA 0.05
  • LICN 0.46
  • MACD
  • DRMA 0.00
  • LICN -0.24
  • Stochastic Oscillator
  • DRMA 44.50
  • LICN 2.86

About DRMA Dermata Therapeutics Inc.

Dermata Therapeutics Inc. is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to development and formulation of singular and combination products that can target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.

About LICN Lichen China Limited

Lichen International Ltd is a financial and taxation service provider in China. The company provides financial and taxation solution services; education support services; and software and maintenance services in the PRC under its Lichen brand. The financial and taxation solution services comprise financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation. The education support services comprise the provision of marketing, operational and technical support and the sales of teaching and learning materials. The software and maintenance services comprise the sales of financial and taxation analysis software and sales of financial and taxation training software.

Share on Social Networks: